Affordable Access

A modulação da resposta imune na colite experimental induzida por TNBS em camundongos da linhagem BALB/c: efeitos da tolerância oral e da transferência adotiva de células dendríticas CD11c+

  • Paiatto, Lisiery Negrini
Publication Date
Aug 31, 2017
Repositório Institucional UNESP
External links


The breakdown of immune tolerance to self antigens is a common mechanism for deleterious immune responses. Several interventions have been proposed to modulate autoimmune responses, such as oral administration of disease-related antigens, adoptive transfer of tolerogenic cells and/or treatment with regulatory cytokines. In this context, it has been demonstrated that the ingestion of protein antigens can generate indirect effects on the immune system of the host, characterized by suppression of the immune response to antigenically unrelated proteins, known as bystander suppression. The present project aims to analyze the indirect effects of oral tolerance induced by ovalbumin (OVA) and by adoptive transfer of tolerant dendritic cells (tDC) in TNBS induced colitis in mice. Our results showed that the treatment of oral OVA mice before or after induction of colitis and the adductive transfer of tDC were able to reduce the signs of the disease, such as weight loss, as well as partially preserve the integrity of the Compared to non-OVA treated animals (controls). The bystander suppression related to OVA consumption appears to favor the expansion of regulatory (regs) T and interleukin (IL)-10 secreting T cells responsible for reducing the clinical manifestations of TNBS-induced colitis. On the other hand, DC obtained from OVA-tolerant animals showed increased expression of CD80. Administration of this cells population to colitic animals was able to reduce the clinical and histological signs of colitis, possibly by reducing Th17 cells, reduction of secretion of Il-17 and IL-9 and augment of IL-10 and IL-4. To the best of our knowledge, there are no data in the literature showing the effect of oral tolerance and the adoptive transfer of tDC in the treatment of colitis.

Report this publication


Seen <100 times